Hygroscopic, -20°C Freezer, Under Inert Atmosphere
Chloroform (Slightly), Methanol (Slightly)
Hygroscopic and Moisture Sensitive
Chiral Reagents, Boron Derivatives, Inhibitors, Pharmaceuticals, Intermediates & Fine Chemicals,
Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway.
Dangerous Goods Info:
Not a dangerous good if item is equal too or less than 1g/ml and there is less than 100g in the package